SLC7A5 and hepatocellular carcinoma: However, all of the CRISPR-Cas9 transporter knockout cell lines were easily maintained long-term cell culture, suggesting that both epithelial and mesenchymal human HCC lines adapt to ASCT2 and LAT1 knockout.